114 related articles for article (PubMed ID: 8278601)
1. Structure-function relationship studies in human cholinesterases reveal genomic origins for individual variations in cholinergic drug responses.
Loewenstein Y; Gnatt A; Neville LF; Zakut H; Soreq H
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Nov; 17(6):905-26. PubMed ID: 8278601
[TBL] [Abstract][Full Text] [Related]
2. Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE.
Neville LF; Gnatt A; Loewenstein Y; Seidman S; Ehrlich G; Soreq H
EMBO J; 1992 Apr; 11(4):1641-9. PubMed ID: 1373381
[TBL] [Abstract][Full Text] [Related]
3. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
Loewenstein Y; Gnatt A; Neville LF; Soreq H
J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
[TBL] [Abstract][Full Text] [Related]
4. [Cholinesterases].
Lejus C; Blanloeil Y; Burnat P; Souron R
Ann Fr Anesth Reanim; 1998; 17(9):1122-35. PubMed ID: 9835982
[TBL] [Abstract][Full Text] [Related]
5. Cholinesterases: new roles in brain function and in Alzheimer's disease.
Giacobini E
Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
[TBL] [Abstract][Full Text] [Related]
6. Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants.
Schwarz M; Loewenstein-Lichtenstein Y; Glick D; Liao J; Norgaard-Pedersen B; Soreq H
Brain Res Mol Brain Res; 1995 Jul; 31(1-2):101-10. PubMed ID: 7476018
[TBL] [Abstract][Full Text] [Related]
7. Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.
Neville LF; Gnatt A; Padan R; Seidman S; Soreq H
J Biol Chem; 1990 Dec; 265(34):20735-8. PubMed ID: 2249982
[TBL] [Abstract][Full Text] [Related]
8. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease.
Small DH; Michaelson S; Sberna G
Neurochem Int; 1996; 28(5-6):453-83. PubMed ID: 8792327
[TBL] [Abstract][Full Text] [Related]
9. Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants.
Darvesh S; Pottie IR; Darvesh KV; McDonald RS; Walsh R; Conrad S; Penwell A; Mataija D; Martin E
Bioorg Med Chem; 2010 Mar; 18(6):2232-2244. PubMed ID: 20181484
[TBL] [Abstract][Full Text] [Related]
10. Use of synthetic oligodeoxynucleotide probes for the isolation of a human cholinesterase cDNA clone.
Prody C; Zevin-Sonkin D; Gnatt A; Koch R; Zisling R; Goldberg O; Soreq H
J Neurosci Res; 1986; 16(1):25-35. PubMed ID: 3755763
[TBL] [Abstract][Full Text] [Related]
11. Interactions of bambuterol with human serum cholinesterase of the genotypes EuEu (normal), EaEa (atypical) and EuEa.
Tunek A; Hjertberg E; Mogensen JV
Biochem Pharmacol; 1991 Feb; 41(3):345-8. PubMed ID: 1994894
[TBL] [Abstract][Full Text] [Related]
12. Planarian cholinesterase: in vitro characterization of an evolutionarily ancient enzyme to study organophosphorus pesticide toxicity and reactivation.
Hagstrom D; Hirokawa H; Zhang L; Radic Z; Taylor P; Collins ES
Arch Toxicol; 2017 Aug; 91(8):2837-2847. PubMed ID: 27990564
[TBL] [Abstract][Full Text] [Related]
13. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
14. Development of acetophenone ligands as potential neuroimaging agents for cholinesterases.
Jollymore-Hughes CT; Pottie IR; Martin E; Rosenberry TL; Darvesh S
Bioorg Med Chem; 2016 Nov; 24(21):5270-5279. PubMed ID: 27637382
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterases, a target of pharmacology and toxicology.
Pohanka M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):219-29. PubMed ID: 22286807
[TBL] [Abstract][Full Text] [Related]
16. Plasma cholinesterase: gene and variations.
Pantuck EJ
Anesth Analg; 1993 Aug; 77(2):380-6. PubMed ID: 8346840
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
18. Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.
Gnatt A; Prody CA; Zamir R; Lieman-Hurwitz J; Zakut H; Soreq H
Cancer Res; 1990 Apr; 50(7):1983-7. PubMed ID: 2317787
[TBL] [Abstract][Full Text] [Related]
19. Expression of cholinesterase genes in human oocytes revealed by in-situ hybridization.
Soreq H; Malinger G; Zakut H
Hum Reprod; 1987 Nov; 2(8):689-93. PubMed ID: 2830295
[TBL] [Abstract][Full Text] [Related]
20. Coumarins as cholinesterase inhibitors: A review.
de Souza LG; Rennã MN; Figueroa-Villar JD
Chem Biol Interact; 2016 Jul; 254():11-23. PubMed ID: 27174134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
